Skip to main content

Table 1 Composition of the investigated FLUSLN and FLUNLC formulations (% w/w)

From: Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies

Formulations

Flurbiprofen

Dynasan 114

Epikuron 200

Captex 355

Polysorbate 80

A (FLUSLN)

1.0

10

2

-

2.5

B (FLUNLC)

1.0

7

2

3

2.5

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X